|
Match
|
Document |
Document Title |
|
|
7569518 |
Pyridazine Compound and Use Thereof
A pyridazine compound represented by formula (1):
has an excellent plant disease controlling effect.
|
|
|
7432381 |
1,3-oxathiolane-2-thione compounds
The present invention relates to 1,3-oxathiolane-2-thione compounds of the general formula (I):
wherein R 1 and R 2 are the same or different, each of which denotes a straight-chain or...
|
|
|
7414145 |
Method of enantioselective nucleophilic addition reaction of enamide to carbonyl group and synthesis method of optically active α-hydroxy-γ-keto acid ester and hydroxydiketone
A method of an enantioselective nucleophilic addition reaction to carbonyl, which enables an asymmetric synthesis of an optically active α-hydroxy-γ-keto acid ester, an optically active...
|
|
|
7378535 |
Production of furanones
The present invention relates to the side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones) and their synthetic analogues, that yields fimbrolides substituted...
|
|
|
7227029 |
Method for the continuous production of N-methyl-2-pyrrolidone (NMP)
Process for the continuous preparation of N-methyl-2-pyrrolidone (NMP) by reacting gamma-butyrolactone (GBL) with monomethylamine (MMA) in the liquid phase, wherein GBL and MMA are used in a molar...
|
|
|
7214641 |
Catalyst and hydrogenation of carbonyl compounds in the liquid phase using the catalyst
The present invention provides a process for hydrogenating carbonyl compounds, in particular C 4 -dicarboxylic acids to mixtures of tetrahydrofuran and gamma-butyrolactone, over supported rhenium...
|
|
|
7183423 |
Process for the preparation of organic compounds with imide catalysts
(A) A compound capable of forming a stable radical and selected from (A1) oxygen-atom-containing compounds each having a carbon-hydrogen bond at the adjacent position to an oxygen atom, (A2)...
|
|
|
7141681 |
Continuous process for preparing dihydropyrones
The invention relates to a continuous process for preparing dihydropyrones of general formula I,
wherein the groups R 1 and R 2 have the meanings described herein.
|
|
|
7109357 |
Process and intermediates for making substituted aspartic acid acetals
Disclosed herein is a method for making compounds that are useful as caspase inhibitor prodrugs of formula I:
wherein R 1 is an optionally substituted group selected from an aliphatic group,...
|
|
|
7101912 |
Carbidopa prodrugs and derivatives, and compositions and uses thereof
Prodrugs of carbidopa, derivatives of carbidopa prodrugs, methods of making prodrugs of carbidopa and derivatives thereof, methods of using prodrugs of carbidopa and derivatives thereof, and...
|
|
|
7038064 |
Process for producing hydroxylactones
A process of the present invention produces a hydroxylactone by subjecting an unsaturated carboxylic acid having a double bond not conjugated to a carboxyl group or an ester thereof to (i) a...
|
|
|
6897324 |
Process for the preparation of 11-oxaprostaglandins and intermediates therein
For the preparation of an 11-oxaprostaglandin such as [2R,(1E,3R),3S,(4Z),4R)]-7-{tetrahydro-2-[4-(3-chlorophenoxy
)-3-hydroxy-1-butenyl]-4-hydroxy-3-furanyl}-4-heptenoic acid and its ester...
|
|
|
6838128 |
High polarization dopants for ferroelectric liquid crystal compositions
The invention relates to chiral nonracemic liquid crystal compounds which are useful as components in liquid crystal compositions to impart high polarization to the mixture. The materials of this...
|
|
|
6835747 |
Ft-0554a substances and process for the preparation thereof
The present invention relates to obtain novel FT-0554A substance useful for infectious disease of parasite, especially helminth and more particularly relates to the novel FT-0554A substance...
|
|
|
6812368 |
Diastereoselective hydrogenation of 1,3-hydroxyketones
The invention relates to a novel process of diastereoselective hydrogenation of 1,3-hydroxyketones of formula (I) wherein R, R′ and R″ are as defined in claim 1 which is carried out in a...
|
|
|
6756013 |
Compositions of iodonium compounds and methods and uses thereof
The present invention provides a composition having biological activity. The composition includes from about 10 ppm to about 5000 parts iodonium salt. The composition also includes from about 100...
|
|
|
6737460 |
Vinyl monomers having polyenic side chains derived from highly unsaturated fatty acids and derivatives thereof, and polymers of said monomers
Vinyl monomers having polyenic side chains derived from highly unsaturated fatty acids represented by the general formula: R 1 COOH wherein R 1 is a C 19-24 hydrocarbon having 5 or 6 unsaturated...
|
|
|
6713639 |
Process for preparing enantiomerically pure (S)-3-hydroxy-gamma-butyrolactone
The present invention relates to a process for the in situ preparation of optically pure (S)-3,4-dihydroxybutyric acid derivatives represented by the Formula [2] and more particularly, to a process...
|
|
|
6713290 |
Process for preparing optically pure (S)-3-hydroxy-&ggr -butyrolactone
The present invention relates to a process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone expressed by the following Formula 1 and more particularly, to a process that enables...
|
|
|
6703515 |
Chiral derivatives of Hibiscus acid bearing lactone ring moiety, process for preparing the same and a convenient method for the large-scale isolation of Hibiscus acid
The present invention relates to a novel chiral compound of Hibiscus acid bearing lactone moiety of formula I, Wherein: R 1 ═R 2 ═alkali salt of carboxylic acid or acid chloride or lower...
|
|
|
6680389 |
Ester compounds
Acrylic esters containing fluorine at α-position and having a lactone ring introduced into the ester side chain thereof are novel. Polymers obtained from the acrylic esters have a high...
|
|
|
6667330 |
Furanone derivatives
Furanone derivatives and the pharmaceutically acceptable salts thereof have cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; they are useful...
|
|
|
6642394 |
Process for producing (meth)acrylic anhydride and process for producing (meth)acrylic ester
(Meth)acrylic acid is reacted with a fatty acid anhydride and the resultant reaction mixture is neutralized and washed with an aqueous alkaline solution having a pH of 7.5 to 13.5. Thus,...
|
|
|
6608214 |
Process for producing optically active &ggr -butyrolactone
This invention provides a novel process for producing optically active 3-hydroxy-γ-butyrolactone in a short step, which is superior economically and in efficiency and industrially suitable by...
|
|
|
6593478 |
Stereospecific hydrolysis of optically active esters
A new, more efficient and highly stereospecific process is described for the preparation of compounds with general formula (R)-(I) and of absolute configuration (R), where the groups M, W, Q and Q...
|
|
|
6576632 |
Biaryl compounds useful as anticancer agents
The present invention relates to compounds of formula I and to pharmaceutically acceptable salts, hydrates and prodrugs thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 10 , R 11 , b, m, n, p...
|
|
|
6541646 |
Method of preparing COX-2 inhibitors
The invention relates to a method for producing compounds of general formula (I) wherein R 1 is selected from the following groups: (a) OR 5 and (b) mono-, di-, or tri-substituted phenyl; and R 2...
|
|
|
6500963 |
Process for preparing optically active dihydropyrones
The invention relates to a new process for preparing optically active dihydropyrones, new intermediate products which may be obtained by this synthesis, and their use as starting compounds in the...
|
|
|
6486196 |
Anticancer compounds: process for their preparation and pharmaceutical compositions containing them
The present invention relates to novel anticancer agents, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, and their pharmaceutically acceptable solvates. The present...
|
|
|
6429319 |
Continuous process for the production of optically pure (S)-beta-hydroxy-gamma-butyrolactone
Disclosed is a process for the production of optically pure (S)-beta-hydroxy-gamma-butyrolactone through the hydrogenation of substituted carboxylic acid derivatives. A solution containing 1 to 50%...
|
|
|
6417377 |
Process for preparing enantiomer-enriched amino- and hydroxyfuranones
A process for the preparation of enantiomer-enriched aminofuranones and hydroxyfuranones in which an enantiomer-enriched cyanohydrin is acylated by an acylating agent, then cyclized at 40 to 90°...
|
|
|
6410590 |
Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them
The present invention relates to novel derivatives of Andrographolide, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, and their pharmaceutically acceptable...
|
|
|
6395724 |
Multibinding inhibitors of cyclooxygenase-2
Disclosed are multibinding compounds which inhibit cyclooxygenase-2 (COX-2), an enzyme which catalyzes the first committed step in the biosynthesis of prostaglandins. The multibinding compounds of...
|
|
|
6313321 |
Process for preparing β-hydroxy-γ-butyrolactones and β-(meth)acryloyloxy-γ-butrolactones
The present invention provides a process for preparing β-hydroxy-γ-butyrolactone or β-methyl-β-hydroxy-γ-butyrolactone represented by the formula (1): ##STR1## wherein R 1 is hydrogen or...
|
|
|
6268515 |
Process for producing 3-hydroxy-γ-butyrolactone derivatives
A process for preparing a 3-hydroxy-γ-butyrolactone derivative represented by the following formula (1): ##STR1## wherein R is C 1 -C 6 alkyl, 3 to 6-membered cycloalkyl, aralkyl, 2-alkenyl,...
|
|
|
6251642 |
Continuous process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone
The present invention relates to a continuous process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone expressed by the following Formula 1 and more particularly, to a process which...
|
|
|
6235899 |
Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
The invention relates to a novel process for preparing compounds of the formula (IV) or (I): ##STR1## from the racemic alkoxyfuranone of the formula (II): ##STR2## R 1 and R 2 being as defined in...
|
|
|
6166070 |
Kodaistatins A, B, C and D, a process for their production and their use
Kodaistatins A and B, compounds of the molecular formula C 35 H 34 O 11 , and Kodaistatins C and D, compounds of the molecular formula C 35 H 34 O 12 , have antidiabetic activity.
|
|
|
6133464 |
Chiral ferrocenyls
The invention relates to chiral ferrocenyls of formula (I) ##STR1## wherein R a is --P(R 10 R 11 ) or --SR 12 ; R b is --P(R' 10 R' 11 ), --SR' 12 , --CHNR 12 , --CH 2 --NH--R 12 or --CH...
|
|
|
6133263 |
Endothelin antagonists with ether-linked groups
Novel nonpeptide endothelin antagonists with ether-linked groups are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating...
|
|
|
6124122 |
Process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone
The present invention relates to a process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone expressed by the following Formula 1 and more particularly, to a process that enables...
|
|
|
6114547 |
Hydroxy-substituted monolactones and use thereof as intermediates for preparing lubricating oil and fuel additives
Compositions comprising hydroxy-substituted monolactones, a process for reacting olefinic compounds with certain carboxylic reactants and products prepared by the process. The compositions...
|
|
|
6100292 |
Ketone derivatives and their medical applications
This invention relates to ketones represented by the following formula ##STR1## and to drugs in which such a ketone or pharmacologically acceptable salt thereof is an effective component. The...
|
|
|
6071954 |
(methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2 inhibitors
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions...
|
|
|
6069270 |
Optical resolution method of (±)-3,4-dihydroxybutanoic acid
An optical resolution method of (±)-3,4-dihydroxybutanoic acid, by reacting (±)-3,4-dihydroxybutanoic acid with an optically active primary amine or secondary amine. Also a method for producing...
|
|
|
6060046 |
Antifouling compositions
An antifouling composition that comprises an effective amount of a furanone of the structure shown and a suitable carrier therefor. In the figure, substituents R 1 , R 2 and R 3 are each a...
|
|
|
6020500 |
Hydroxy-substituted monolactones useful as intermediates for preparing lubricating oil and fuel additives
Compositions comprising hydroxy-substituted monolactones, a process for reacting olefinic compounds with certain carboxylic reactants and products prepared by the process. The compositions...
|
|
|
5998633 |
Process for the synthesis of protected esters of (S)-3,4-dihydroxybutyric acid
The invention is an improved process for the preparation of a compound of formula I wherein R and R 1 are each independently alkyl of from 1 to 3 carbon atoms; and R 2 is alkyl of from 1 to 8...
|
|
|
5986112 |
Vitamin D.sup.3 derivative and production process thereof
A vitamin D 3 derivative represented by the following formula: wherein, R is, independently, a hydrogen atom, tri(C 1 to C 7 hydrocarbon)silyl group, C 2 to C 8 acyl group, or group forming an...
|
|
|
5977169 |
Substituted tetronic acids useful for treating HIV and other retroviruses
This invention comprises novel substituted tetronic acid type compounds, 2, 4(3H, 5H)-furandiones, that are useful for the inhibition of the HIV protease enzyme. The compounds may be useful for the...
|